Cargando...
Cholesterol Ester Transfer Protein Inhibitor Review
Treatment of blood cholesterol is part of a strategy to lower atherosclerotic cardiovascular (ASCVD) risk. While use of HMG-CoA reductase inhibitors to modify cholesterol levels is the primary means of lowering the risk of an ASCVD event, residual risk remains. A new strategy being investigated is t...
Gardado en:
| Publicado en: | Hosp Pharm |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5735735/ https://ncbi.nlm.nih.gov/pubmed/29276295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578717729669 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|